BSA
Braun Stacey Associates Portfolio holdings
AUM
$2.76B
This Quarter Return
+12.78%
1 Year Return
+37.99%
3 Year Return
+184.8%
5 Year Return
+344.47%
10 Year Return
+1,027.82%
AUM
$1.75B
AUM Growth
+$1.75B
(+7.5%)
Cap. Flow
-$32.2M
Cap. Flow
% of AUM
-1.84%
Top 10 Holdings %
Top 10 Hldgs %
16.51%
Holding
165
New
17
Increased
26
Reduced
98
Closed
14
Top Buys
| 1 |
Mastercard
MA
|
$24.5M |
| 2 |
AGN
Allergan plc
AGN
|
$16.8M |
| 3 |
Trinity Industries
TRN
|
$13.6M |
| 4 |
SBNY
Signature Bank
SBNY
|
$11.5M |
| 5 |
Lam Research
LRCX
|
$10.5M |
Top Sells
| 1 |
Owens Corning
OC
|
$12.2M |
| 2 |
Tenet Healthcare
THC
|
$8.44M |
| 3 |
CTRX
CATAMARAN CORP COM STK (CDA)
CTRX
|
$7.81M |
| 4 |
Jazz Pharmaceuticals
JAZZ
|
$5.33M |
| 5 |
Cisco
CSCO
|
$4.71M |
Sector Composition
| 1 | Financials | 16.59% |
| 2 | Technology | 14.06% |
| 3 | Healthcare | 13.9% |
| 4 | Industrials | 11.46% |
| 5 | Consumer Discretionary | 10.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Capri Holdings
CPRI
$2.45B
| $20.2M | 1.15% |
248,240
-10,810
| -4% | -$878K |
|
27
Pfizer
PFE
$141B
| $19.8M | 1.14% |
647,524
-25,028
| -4% | -$767K |
|
|
MON
28
DELISTED
Monsanto Co
MON
| $19.6M | 1.12% |
168,490
+675
| +0.4% | +$78.7K |
|
|
INVN
29
DELISTED
Invensense Inc
INVN
| $19.6M | 1.12% |
942,839
-1,771
| -0.2% | -$36.8K |
|
30
Polaris
PII
$3.18B
| $19.3M | 1.1% |
132,232
+432
| +0.3% | +$62.9K |
|
31
Johnson & Johnson
JNJ
$427B
| $19.2M | 1.1% |
209,928
-6,097
| -3% | -$558K |
|
32
LKQ Corp
LKQ
$8.39B
| $19.1M | 1.09% |
579,510
-41,895
| -7% | -$1.38M |
|
|
AZPN
33
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $18.9M | 1.08% |
452,628
-11,062
| -2% | -$462K |
|
34
Amphenol
APH
$133B
| $18.8M | 1.07% |
210,442
-3,450
| -2% | -$308K |
|
35
NXP Semiconductors
NXPI
$59.2B
| $18.6M | 1.06% |
404,382
-12,118
| -3% | -$557K |
|
36
Wells Fargo
WFC
$263B
| $18.3M | 1.05% |
403,528
-41,311
| -9% | -$1.88M |
|
37
Danaher
DHR
$147B
| $18.2M | 1.04% |
236,031
+6,505
| +3% | +$502K |
|
38
MetLife
MET
$54.1B
| $17.8M | 1.02% |
330,474
-355
| -0.1% | -$19.1K |
|
39
Fiserv
FI
$75.1B
| $17.8M | 1.02% |
301,515
+143,715
| +91% | +$8.49M |
|
40
Merck
MRK
$210B
| $17.8M | 1.02% |
354,698
-3,173
| -0.9% | -$159K |
|
41
Paychex
PAYX
$50.2B
| $17.7M | 1.01% |
388,635
-19,905
| -5% | -$906K |
|
|
CB
42
DELISTED
CHUBB CORPORATION
CB
| $17.6M | 1.01% |
182,621
-12,182
| -6% | -$1.18M |
|
43
Goldman Sachs
GS
$226B
| $17.6M | 1.01% |
99,406
-9,252
| -9% | -$1.64M |
|
44
Elevance Health
ELV
$71.8B
| $17.5M | 1% |
189,850
-1,445
| -0.8% | -$134K |
|
45
US Bancorp
USB
$76B
| $17.5M | 1% |
432,177
-36,078
| -8% | -$1.46M |
|
46
Oceaneering
OII
$2.45B
| $17.4M | 0.99% |
220,330
-10,925
| -5% | -$862K |
|
47
Travelers Companies
TRV
$61.1B
| $17.4M | 0.99% |
191,688
-19,433
| -9% | -$1.76M |
|
48
Qualcomm
QCOM
$173B
| $17.2M | 0.98% |
231,340
-11,790
| -5% | -$875K |
|
|
AGN
49
DELISTED
Allergan plc
AGN
| $16.8M | 0.96% |
+99,951
| New | +$16.8M |
|
50
CSX Corp
CSX
$60.6B
| $16.8M | 0.96% |
583,229
+6,900
| +1% | +$199K |
|